Improving diversity in cancer care teams
Diversity in the Cancer Care Workforce
This study is looking at how having a diverse cancer care team—made up of doctors from different racial and ethnic backgrounds—can improve the treatment and experiences of patients with cancer, so that everyone gets better care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11003358 on NIH RePORTER |
What this research studies
This research investigates the impact of racial and ethnic diversity within cancer care teams on the quality of care and outcomes for patients. By analyzing data that links the demographics of oncologists with patient clinical data, the study aims to determine if greater diversity among healthcare providers leads to better cancer treatment experiences and results. The research will focus on understanding how patient-provider racial and ethnic concordance affects care quality, with the goal of generating actionable insights to enhance workforce diversity and equity in cancer care.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients receiving cancer treatment who are interested in how provider diversity may affect their care experience.
Not a fit: Patients who are not currently undergoing cancer treatment or who do not have access to diverse cancer care teams may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer care and outcomes for all patients by promoting diversity in the healthcare workforce.
How similar studies have performed: Previous research in other fields has shown that diversity in teams can enhance performance, suggesting potential for success in this area, although this specific approach is relatively novel.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Gross, Cary P. — Yale University
- Study coordinator: Gross, Cary P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.